Palazestrant
Palazestrant(OP-1250) is an orally bioavailable complete antagonist of estrogen receptor (ER) that blocks ER activity. It exhibits antiproliferative and antitumor activity in ER-positive (ER+) breast cancer models.
| Trivial name | OP-1250 |
| Catalog Number | E1842 |
| CAS# | 2092925-89-6 |
| Size | 5mg |
| Supplier Page | http://www.selleckchem.com/products/palazestrant.html |
| Additional Information | https://file.selleck.cn/downloads/struct/E1842-Palazestrant-chemical-structure.png |